As access to Anthropic’s and OpenAI’s frontier models becomes more restricted, Chinese labs are pitching their open-source alternatives as stable, accessible, and increasingly capable.
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
Chinese brands edged out Japanese names in Western Europe during the second quarter for the first time, while VW brand led local losers in the first half.
Americans want the AI boom. They just do not want it on their street. A new poll finds most US residents would rather not live near an AI data centre. Yet the same buildings quietly bankroll schools where they cluster. More than half of US residents, 5…
YouTube creator Gossip Goblin brings AI-assisted feature “Gods Don’t Give Gifts” to U.S. theaters, testing whether online fandom can drive box office.
YouTube creator Gossip Goblin brings AI-assisted feature “Gods Don’t Give Gifts” to U.S. theaters, testing whether online fandom can drive box office.
Amelia Dimoldenberg expands her YouTube empire with the return of her Formula 1 collaboration ‘Passenger Princess.’
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
NEURA Robotics is opening ‘gyms’ where robots train under real-world conditions, starting with two German universities. Its bet is that the thing holding humanoids back is not intelligence, but a shortage of real experience. The German robotics firm NE…
The ChatGPT maker has put two banking chiefs on both its nonprofit and for-profit boards: Nubank’s David Vélez and BNY’s Robin Vince. It is the kind of Wall Street ballast a company assembles when it is getting ready to face public investors. OpenAI is…